메뉴 건너뛰기




Volumn 88, Issue 1, 2010, Pages 79-87

Erratum: Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation (Clinical Pharmacology & Therapeutics (2010) 88 (79-87) DOI: 10.1038/clpt.2010.54);Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation

Author keywords

[No Author keywords available]

Indexed keywords

CORIFOLLITROPIN ALFA; GONADORELIN AGONIST; INHIBIN B; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

EID: 77953812818     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.163     Document Type: Erratum
Times cited : (43)

References (23)
  • 1
    • 0029925931 scopus 로고    scopus 로고
    • Impact of the in-vitro fertilization process on emotional, physical and relational variables
    • Boivin, J. & Takefman, J.E. Impact of the in-vitro fertilization process on emotional, physical and relational variables. Hum. Reprod. 11, 903-907 (1996).
    • (1996) Hum. Reprod. , vol.11 , pp. 903-907
    • Boivin, J.1    Takefman, J.E.2
  • 2
    • 0035988486 scopus 로고    scopus 로고
    • Single dose pharmacokinetics and efects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females
    • Duijkers, I.J., Klipping, C., Boerrigter, P.J., Machielsen, C.S., De Bie, J.J. & Voortman, G. Single dose pharmacokinetics and efects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females. Hum. Reprod. 17, 1987-1993 (2002).
    • (2002) Hum. Reprod. , vol.17 , pp. 1987-1993
    • Duijkers, I.J.1    Klipping, C.2    Boerrigter, P.J.3    MacHielsen, C.S.4    De Bie, J.J.5    Voortman, G.6
  • 3
    • 0026551294 scopus 로고
    • Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit
    • Fares, F.A., Suganuma, N., Nishimori, K., LaPolt, P.S., Hsueh, A.J. & Boime, I. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc. Natl. Acad. Sci. U.S.A. 89, 4304-4308 (1992).
    • (1992) Proc. Natl. Acad. Sci. U.S.A. , vol.89 , pp. 4304-4308
    • Fares, F.A.1    Suganuma, N.2    Nishimori, K.3    Lapolt, P.S.4    Hsueh, A.J.5    Boime, I.6
  • 4
    • 2442425992 scopus 로고    scopus 로고
    • Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization
    • Devroey, P., Fauser, B.C., Platteau, P., Beckers, N.G., Dhont, M. & Mannaerts, B.M. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. J. Clin. Endocrinol. Metab. 89, 2062-2070 (2004)
    • (2004) J. Clin. Endocrinol. Metab. , vol.89 , pp. 2062-2070
    • Devroey, P.1    Fauser, B.C.2    Platteau, P.3    Beckers, N.G.4    Dhont, M.5    Mannaerts, B.M.6
  • 5
    • 54149099792 scopus 로고    scopus 로고
    • A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation
    • The Corifollitropin Alfa Dose-Finding Study Group
    • The Corifollitropin Alfa Dose-Finding Study Group. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Hum. Reprod. 23, 2484-2492 (2008).
    • (2008) Hum. Reprod. , vol.23 , pp. 2484-2492
  • 6
    • 0035989359 scopus 로고    scopus 로고
    • Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome
    • Fawzy, M. et al. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Hum. Reprod. 17, 1535-1543 (2002).
    • (2002) Hum. Reprod. , vol.17 , pp. 1535-1543
    • Fawzy, M.1
  • 7
    • 27944501145 scopus 로고    scopus 로고
    • Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome
    • Eldar-Geva, T. et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum. Reprod. 20, 3178-3183 (2005).
    • (2005) Hum. Reprod. , vol.20 , pp. 3178-3183
    • Eldar-Geva, T.1
  • 8
    • 0036712130 scopus 로고    scopus 로고
    • Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders
    • Eldar-Geva, T. et al. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum. Reprod. 17, 2331-2337 (2002).
    • (2002) Hum. Reprod. , vol.17 , pp. 2331-2337
    • Eldar-Geva, T.1
  • 9
    • 0034453913 scopus 로고    scopus 로고
    • Relationship between serum inhibin A and B and ovarian follicle development after a daily fxed dose administration of recombinant follicle-stimulating hormone
    • Eldar-Geva, T. et al. Relationship between serum inhibin A and B and ovarian follicle development after a daily fxed dose administration of recombinant follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 85, 607-613 (2000).
    • (2000) J. Clin. Endocrinol. Metab. , vol.85 , pp. 607-613
    • Eldar-Geva, T.1
  • 10
    • 0031426576 scopus 로고    scopus 로고
    • A population model for the follicular growth in women treated with follicle stimulating hormone
    • Karlsson, M.O., Wade, J.R., Loumaye, E. & Munafo, A. A population model for the follicular growth in women treated with follicle stimulating hormone. Clin. Pharmacol. Ther. 62, 665-674 (1997).
    • (1997) Clin. Pharmacol. Ther. , vol.62 , pp. 665-674
    • Karlsson, M.O.1    Wade, J.R.2    Loumaye, E.3    Munafo, A.4
  • 11
    • 0029995406 scopus 로고    scopus 로고
    • Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon)
    • Mitchell, R. et al. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon). Hum. Reprod. 11, 962-967 (1996).
    • (1996) Hum. Reprod. , vol.11 , pp. 962-967
    • Mitchell, R.1
  • 12
    • 72949112470 scopus 로고    scopus 로고
    • A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the frst seven days of ovarian stimulation using a GnRH antagonist protocol
    • ENGAGE Investigators
    • Devroey, P., Boostanfar, R., Koper, N.P., Mannaerts, B.M., Ijzerman-Boon, P.C. & Fauser, B.C.; ENGAGE Investigators. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the frst seven days of ovarian stimulation using a GnRH antagonist protocol. Hum. Reprod. 24, 3063-3072 (2009).
    • (2009) Hum. Reprod. , vol.24 , pp. 3063-3072
    • Devroey, P.1    Boostanfar, R.2    Koper, N.P.3    Mannaerts, B.M.4    Ijzerman-Boon, P.C.5    Fauser, B.C.6
  • 13
    • 77953807878 scopus 로고    scopus 로고
    • Corifollitropin alfa for controlled ovarian stimulation in IVF treatment: Results from a randomized trial in lower body weight women
    • Corifollitropin alfa ENSURE study group Online, in press.
    • Mannaerts, B.; Corifollitropin alfa ENSURE study group. Corifollitropin alfa for controlled ovarian stimulation in IVF treatment: results from a randomized trial in lower body weight women. Reprod. Biomed. Online, in press.
    • Reprod. Biomed
    • Mannaerts, B.1
  • 14
    • 10344231983 scopus 로고    scopus 로고
    • Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility
    • Balen, A.H. et al. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility. J. Clin. Endocrinol. Metab. 89, 6297-6304 (2004).
    • (2004) J. Clin. Endocrinol. Metab. , vol.89 , pp. 6297-6304
    • Balen, A.H.1
  • 15
    • 0036773437 scopus 로고    scopus 로고
    • A group-comparative, randomized, double-blind comparison of the efcacy and efciency of two fxed daily dose regimens (100-and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF/ICSI
    • Asian Purgeon Study Group
    • Hoomans, E.H. & Mulder, B.B.; Asian Purgeon Study Group. A group-comparative, randomized, double-blind comparison of the efcacy and efciency of two fxed daily dose regimens (100-and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF/ICSI. J. Assist. Reprod. Genet. 19, 470-476 (2002).
    • (2002) J. Assist. Reprod. Genet. , vol.19 , pp. 470-476
    • Hoomans, E.H.1    Mulder, B.B.2
  • 16
    • 0032997924 scopus 로고    scopus 로고
    • A prospective, randomized, double-blind clinical trial to study the efcacy and efciency of a fxed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation
    • Out, H.J. et al. A prospective, randomized, double-blind clinical trial to study the efcacy and efciency of a fxed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation. Hum. Reprod. 14, 622-627 (1999).
    • (1999) Hum. Reprod. , vol.14 , pp. 622-627
    • Out, H.J.1
  • 17
    • 0033963346 scopus 로고    scopus 로고
    • Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation
    • Out, H.J. et al. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum. Reprod. 15, 29-35 (2000).
    • (2000) Hum. Reprod. , vol.15 , pp. 29-35
    • Out, H.J.1
  • 18
    • 0034969673 scopus 로고    scopus 로고
    • A randomized, double-blind clinical trial using fxed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles
    • Out, H.J. et al. A randomized, double-blind clinical trial using fxed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles. Hum. Reprod. 16, 1104-1109 (2001)
    • (2001) Hum. Reprod. , vol.16 , pp. 1104-1109
    • Out, H.J.1
  • 19
    • 0034755127 scopus 로고    scopus 로고
    • A double-blind clinical trial comparing a fxed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization
    • Latin American Puregon Study Group
    • Latin American Puregon Study Group. A double-blind clinical trial comparing a fxed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization. Fertil. Steril. 76, 950-956 (2001).
    • (2001) Fertil. Steril. , vol.76 , pp. 950-956
  • 20
    • 0033807688 scopus 로고    scopus 로고
    • Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is efective, safe and convenient: Results of a controlled, randomized, multicentre trial
    • The European Orgalutran Study Group
    • Borm, G. & Mannaerts, B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is efective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum. Reprod. 15, 1490-1498 (2000).
    • (2000) Hum. Reprod. , vol.15 , pp. 1490-1498
    • Borm, G.1    Mannaerts, B.2
  • 21
    • 0035161913 scopus 로고    scopus 로고
    • Efcacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation
    • North American Ganirelix Study Group
    • Fluker, M. et al.; North American Ganirelix Study Group. Efcacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil. Steril. 75, 38-45 (2001)
    • (2001) Fertil. Steril. , vol.75 , pp. 38-45
    • Fluker, M.1
  • 22
    • 0035070776 scopus 로고    scopus 로고
    • Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation
    • European and Middle East Orgalutran Study Group
    • European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum. Reprod. 16, 644-651 (2001).
    • (2001) Hum. Reprod. , vol.16 , pp. 644-651
  • 23
    • 29144499138 scopus 로고    scopus 로고
    • A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profles in GnRH antagonist-treated patients
    • Orgalutran Scheduling Study Group
    • Rombauts, L., Healy, D. & Norman, R.J.; Orgalutran Scheduling Study Group. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profles in GnRH antagonist-treated patients. Hum. Reprod. 21, 95-103 (2006).
    • (2006) Hum. Reprod. , vol.21 , pp. 95-103
    • Rombauts, L.1    Healy, D.2    Norman, R.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.